Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Hedge Funds

13G Filing: Biotechnology Value Fund LP and Oncomed Pharmaceuticals Inc (OMED)

Published on April 28, 2017 at 1:00 pm by Insider Monkey Staff in Hedge Funds
<< Prev
Page 10 of 13
Next >>
See All

Page 10 of 13 – SEC Filing

Item 2(e). CUSIP Number:

68234X102

Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person
Filing is a:
/x/ Not applicable.
(a) / / Broker or dealer registered under Section 15 of the Exchange Act.
(b) / / Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) / / Insurance company as defined in Section 3(a)(19) of the Exchange Act.
(d) / / Investment company registered under Section 8 of the Investment Company Act.
(e) / / An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
(f) / / An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
(g) / / A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
(h) / / A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
(i) / / A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act.
(j) / / Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
(k) / / Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____
Item 4. Ownership
(a) Amount beneficially owned:

As of the close of business on April
27, 2017 (i) BVF beneficially owned 1,372,923 shares of Common Stock, (ii) BVF2 beneficially owned 899,819 shares of Common Stock,
and (iii) Trading Fund OS beneficially owned 249,098 shares of Common Stock.

Partners OS as the general partner
of Trading Fund OS may be deemed to beneficially own the 249,098 shares of Common Stock beneficially owned by Trading Fund OS.

Partners, as the general partner of
BVF, BVF2, the investment manager of Trading Fund OS, and the sole member of Partners OS, may be deemed to beneficially own the
2,985,489 shares of Common Stock beneficially owned in the aggregate by BVF, BVF2, Trading Fund OS, and certain Partners managed
accounts (the “Partners Managed Accounts”), including 463,649 shares of Common Stock held in the Partners Managed Accounts.

10

Follow Oncomed Pharmaceuticals Inc (NASDAQ:OMED)
<< Prev
Page 10 of 13
Next >>
See All

Related Insider Monkey Articles
13G Filing: David Forster and Homeland Resources Ltd. (HMLA)13G Filing: 683 Capital Partners and Innocoll Holdings PLC (INNL)
13G Filing: HBK Investments and Vantage Energy Acquisition Corp (VEACU)13G Filing: James E. Flynn and Audentes Therapeutics Inc (BOLD)
13G Filing: Soroban Capital Partners and Praxair Inc (PX)13G Filing: Becker Drapkin Management and ARC Group WorldWide Inc (ARCW)